Inmode Stock Earnings Reports

InMode reported Q1 2026 revenue of $82.0M, up 5% year-over-year, with international sales at $38.7M (48% of total). GAAP gross margin was 75% (down from 78% YoY) and non-GAAP gross margin was 75% (down from 79% YoY). GAAP diluted EPS was $0.18 and non-GAAP diluted EPS was $0.25. Management highlighted early signs of stabilization in the U.S. market and organizational changes in North America (new leadership, a move to a unified North American model, and an independent Envision ophthalmology/optometry sales team) intended to improve coordination and accountability. Product strategy emphasized expanding laser offerings (Pico, CO2/Solaria, and a forthcoming Erbium) to deliver a one-stop-shop solution for physicians, acknowledging these platforms may pressure gross margins but strengthen competitive positioning and customer relationships. The company maintained a strong balance sheet with cash, marketable securities and deposits of $537.2M and emphasized continued share repurchases (noting significant prior repurchases and activity under the 2026 program). CFO Yair Malca announced he will step down and remain as a consultant for six months. Management reiterated full-year 2026 guidance: revenue $365M–$375M; non-GAAP gross margin 74%–76%; non-GAAP operating income $73M–$78M; non-GAAP diluted EPS $1.33–$1.38. Management said all capital allocation options remain on the table (buybacks, potential M&A, dividends), though acquisition valuations remain a constraint.